GotoPER - Physicians' Education Resource
Back to Home
Free CE/CMEVideo

PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC—Expert Perspectives on New Approvals and Emerging Strategies

Create AccountAlready Registered? Login Here

Release Date

July 11, 2025

Expiration Date

July 12, 2026

Credits

2.0 CME, NCPD

Specialties

General Oncology, Lung Cancer+5 more

Release Date: July 11, 2025

Expiration Date: July 11, 2026

Activity Overview

This educational activity is an archive of the live presentation held on Sunday, June 1, 2025.

For more information about this educational activity, the faculty, and disclosures, please click here.

Target Audience

This educational activity is directed toward physicians, nurses, nurse practitioners, physician assistants, and other health care providers involved in the treatment and management of small cell lung cancer (SCLC).

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Discuss current trial data describing novel strategies for the management of limited- and extensive-stage SCLC
  • Apply clinical trial evidence supporting the efficacy and safety of SCLC treatment across lines of care in real-world case-based scenarios
  • Plan proactive strategies to mitigate and manage treatment-related adverse events in patients with SCLC
PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC—Expert Perspectives on New Approvals and Emerging Strategies

GET STARTED WITH THIS PROGRAM:

Register now to gain access to this program.

Create AccountAlready Registered? Login Here

Accreditation/Credit Designation

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Amgen, Inc; AstraZeneca; and Boehringer Ingelheim, Inc.

Related Content

Course

PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC—Expert Perspectives on New Approvals and Emerging Strategies

Create Account